Gallagher Fiduciary Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$141K	Buy	13,347 +2,361	+21%	+$25K	0.01%	311
2025 Q1	$165K	Buy	+10,986	New	+$165K	0.01%	294
2024 Q4	–	Sell	-8,809	Closed	-$218K	–	299
2024 Q3	$218K	Buy	+8,809	New	+$218K	0.04%	245